Search Within

Nora Katabi

  1. "Head and Neck Service"
Formats
  1. Journal Article (48)
  2. Meeting Abstract (27)
  3. Research Letter (1)
Groups
  1. Department of Medicine (76)
  2. Department of Pathology and Laboratory Medicine (76)
  3. Head and Neck Service (76)
  4. Solid Tumor Oncology Division (76)
  5. Surgery (47)
  6. Radiation Oncology, Department of (35)

More Groups

People
  1. Eric Sherman (50)
  2. Alan Ho (48)
  3. David Pfister (35)
  4. Nancy Lee (31)
  5. Nadeem Riaz (26)
  6. Luc Morris (25)

More People

Years
  1. 2025 (2)
  2. 2024 (6)
  3. 2023 (5)
  4. 2022 (5)
  5. 2021 (3)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. International Journal of Radiation Oncology, Biology, Physics (11)
  3. Annals of Oncology (6)
  4. Head & Neck (6)
  5. Modern Pathology (4)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (18)
  2. Elsevier Inc. (14)
  3. Oxford University Press (7)
  4. John Wiley & Sons, Inc. (6)
  5. Wiley Blackwell (6)
  6. Nature Publishing Group (5)

More Publishers

Results (76)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of lenvatinib plus pembrolizumab in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Mohamadpour, M.; Sherman, E. J.; Kriplani, A.; Fetten, J. V.; Dunn, L.; Michel, L. S.; Hung, K. W.; Baxi, S. S.; McDonald, E.; Conybeare, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Stem cell-like T cell depletion in the recurrent head and neck cancer immune microenvironment
    Journal Article

    Chen, L.; Lee, N.; Sarkar, R.; Katabi, N.; Li, Y.; Morris, L.; Wong, R.; Sherman, E.; Reis-Filho, J. S.; Hollmann, T.; more...
    OncoImmunology (2023)

    Fulltext@MSK | Save
  • Loss of CDKN2A/B is a molecular marker of high-grade histology and is associated with aggressive behavior in acinic cell carcinoma
    Journal Article

    Dogan, S.; Xu, B.; Rana, S.; Chen, H.; Ghossein, R. A.; Berger, M. F.; Ho, A. L.; Katabi, N.
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide for patients with androgen receptor-positive salivary gland cancers (Alliance A091404)
    Journal Article

    Ho, A. L.; Foster, N. R.; Zoroufy, A. J.; Campbell, J. D.; Worden, F.; Price, K.; Adkins, D.; Bowles, D. W.; Kang, H. Y. S.; Burtness, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Ho, A. L.; Ganly, I.; Riaz, N.; Morris, L.; Hung, K. W.; Kriplani, A.; Cracchiolo, J. R.; Cohen, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Head and neck acinic cell carcinoma: A new grading system proposal and diagnostic utility of NR4A3 immunohistochemistry
    Journal Article

    Xu, B.; Saliba, M.; Ho, A.; Viswanathan, K.; Alzumaili, B.; Dogan, S.; Ghossein, R.; Katabi, N.
    American Journal of Surgical Pathology (2022)

    Fulltext@MSK | Save
  • Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirusā€“related malignancies
    Journal Article

    Burman, B.; Drutman, S. B.; Fury, M. G.; Wong, R. J.; Katabi, N.; Ho, A. L.; Pfister, D. G.
    Oral Oncology (2022)

    Fulltext@MSK | Save
  • Primary high-grade non-anaplastic thyroid carcinoma: A retrospective study of 364 cases
    Journal Article

    Xu, B.; David, J.; Dogan, S.; Landa, I.; Katabi, N.; Saliba, M.; Khimraj, A.; Sherman, E. J.; Tuttle, R. M.; Tallini, G.; more...
    Histopathology (2022)

    Fulltext@MSK | Save
  • Precision radiotherapy: Reduction in radiation for oropharyngeal cancer in the 30 ROC trial
    Journal Article

    Riaz, N.; Sherman, E.; Pei, X.; SchoĢˆder, H.; Grkovski, M.; Paudyal, R.; Katabi, N.; Selenica, P.; Yamaguchi, T. N.; Ma, D.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • TERT promoter mutations are enriched in oral cavity cancers and associated with locoregional recurrence
    Journal Article

    Yu, Y.; Fan, D.; Song, X.; Zakeri, K.; Chen, L.; Kang, J.; McBride, S.; Tsai, C. J.; Dunn, L.; Sherman, E.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save